Global Sexual Dysfunction Drugs Market Report, History and Forecast 2018-2029, Breakdown Data by Manufacturers, Key Regions, Types and Application

• Description
• Table of Contents
• Table of Figures
• PDF Download

• Description
• Table of Contents
• Table of Figures
• PDF Download

Sexual dysfunctions include sexual disorders of men and women that can interfere with their sexual performance, leading to unsatisfied sexual intercourse. The major drugs used in this market are PDE5 inhibitors, whereas other drugs such as hormone-related and transurethral also have a presence in the market.

Sexual Dysfunction Drugs report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Sexual Dysfunction Drugs market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Demand from Male and Female are the major drivers for the industry.

The sexual dysfunction oral drugs segment accounted for the majority market share during 2017 and will continue to grow during the forecast period. The increasing cases of sexual dysfunctions are driving the need for oral therapies such as 5HT1A receptor agonist. The demand for sexual dysfunction oral drugs such as ED drugs will further increase due to the rising awareness among healthcare professionals.

Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Sexual Dysfunction Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Manufacturers, Type, User and Regions Listed in the Report:
By Company
    Pfizer
    GlaxoSmithKline
    Merck
    Eli Lilly
    AbbVie
    Bayer
    Teva Pharmaceutical Industries
    Takeda
    Apricus Biosciences
    Emotional Brain
    Ivix LLX
    Leadiant Biosciences
    NexMed
    S1 Biopharma
    Vietstar Biomedical Research

Segment by Type
    Oral Therapy
    Intracavernosal Therapy
    Hormonal Therapy
    Transurethral Therapy

Segment by User
    Male
    Female

Segment by Region
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        China Taiwan
        Indonesia
        Thailand
        Malaysia
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

Each chapter of the report provides detailed information for readers to understand the Sexual Dysfunction Drugs market further:
Chapter 1: Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 2: Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Sexual Dysfunction Drugs, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Sexual Dysfunction Drugs industry.
Chapter 3: Historical (2018-2022) and forecast (2023-2029) volume and revenue analysis of Sexual Dysfunction Drugs in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4: Product User, Volume and Revenue analysis of Each User in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 5 to 9: Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10: Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Sexual Dysfunction Drugs introduction, etc. Sexual Dysfunction Drugs Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11: Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12: Market Channel, Distributors and Customers are listed.
Chapter 13: QYResearch’s Conclusions of Sexual Dysfunction Drugs market based on comprehensive survey.
Chapter 14: Methodology and Data Sources adopted by QYResearch.

 1 Sexual Dysfunction Drugs Market Overview
    1.1 Sexual Dysfunction Drugs Product Overview
    1.2 Sexual Dysfunction Drugs Market Segment by Type
        1.2.1 Oral Therapy
        1.2.2 Intracavernosal Therapy
        1.2.3 Hormonal Therapy
        1.2.4 Transurethral Therapy
    1.3 Global Sexual Dysfunction Drugs Market Size by Type
        1.3.1 Global Sexual Dysfunction Drugs Market Size Overview by Type (2018-2029)
        1.3.2 Global Sexual Dysfunction Drugs Historic Market Size Review by Type (2018-2023)
        1.3.3 Global Sexual Dysfunction Drugs Forecasted Market Size by Type (2024-2029)
    1.4 Key Regions Market Size Segment by Type
        1.4.1 North America Sexual Dysfunction Drugs Sales Breakdown by Type (2018-2023)
        1.4.2 Europe Sexual Dysfunction Drugs Sales Breakdown by Type (2018-2023)
        1.4.3 Asia-Pacific Sexual Dysfunction Drugs Sales Breakdown by Type (2018-2023)
        1.4.4 Latin America Sexual Dysfunction Drugs Sales Breakdown by Type (2018-2023)
        1.4.5 Middle East and Africa Sexual Dysfunction Drugs Sales Breakdown by Type (2018-2023)

 2 Global Sexual Dysfunction Drugs Market Competition by Company
    2.1 Global Top Players by Sexual Dysfunction Drugs Sales (2018-2023)
    2.2 Global Top Players by Sexual Dysfunction Drugs Revenue (2018-2023)
    2.3 Global Top Players by Sexual Dysfunction Drugs Price (2018-2023)
    2.4 Global Top Manufacturers Sexual Dysfunction Drugs Manufacturing Base Distribution, Sales Area, Product Type
    2.5 Sexual Dysfunction Drugs Market Competitive Situation and Trends
        2.5.1 Sexual Dysfunction Drugs Market Concentration Rate (2018-2023)
        2.5.2 Global 5 and 10 Largest Manufacturers by Sexual Dysfunction Drugs Sales and Revenue in 2022
    2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Sexual Dysfunction Drugs as of 2022)
    2.7 Date of Key Manufacturers Enter into Sexual Dysfunction Drugs Market
    2.8 Key Manufacturers Sexual Dysfunction Drugs Product Offered
    2.9 Mergers & Acquisitions, Expansion

 3 Sexual Dysfunction Drugs Status and Outlook by Region
    3.1 Global Sexual Dysfunction Drugs Market Size and CAGR by Region: 2018 VS 2022 VS 2029
    3.2 Global Sexual Dysfunction Drugs Historic Market Size by Region
        3.2.1 Global Sexual Dysfunction Drugs Sales in Volume by Region (2018-2023)
        3.2.2 Global Sexual Dysfunction Drugs Sales in Value by Region (2018-2023)
        3.2.3 Global Sexual Dysfunction Drugs Sales (Volume & Value) Price and Gross Margin (2018-2023)
    3.3 Global Sexual Dysfunction Drugs Forecasted Market Size by Region
        3.3.1 Global Sexual Dysfunction Drugs Sales in Volume by Region (2024-2029)
        3.3.2 Global Sexual Dysfunction Drugs Sales in Value by Region (2024-2029)
        3.3.3 Global Sexual Dysfunction Drugs Sales (Volume & Value), Price and Gross Margin (2024-2029)

 4 Global Sexual Dysfunction Drugs by User
    4.1 Sexual Dysfunction Drugs Market Segment by User
        4.1.1 Male
        4.1.2 Female
    4.2 Global Sexual Dysfunction Drugs Market Size by User
        4.2.1 Global Sexual Dysfunction Drugs Market Size Overview by User (2018-2029)
        4.2.2 Global Sexual Dysfunction Drugs Historic Market Size Review by User (2018-2023)
        4.2.3 Global Sexual Dysfunction Drugs Forecasted Market Size by User (2024-2029)
    4.3 Key Regions Market Size Segment by User
        4.3.1 North America Sexual Dysfunction Drugs Sales Breakdown by User (2018-2023)
        4.3.2 Europe Sexual Dysfunction Drugs Sales Breakdown by User (2018-2023)
        4.3.3 Asia-Pacific Sexual Dysfunction Drugs Sales Breakdown by User (2018-2023)
        4.3.4 Latin America Sexual Dysfunction Drugs Sales Breakdown by User (2018-2023)
        4.3.5 Middle East and Africa Sexual Dysfunction Drugs Sales Breakdown by User (2018-2023)

 5 North America Sexual Dysfunction Drugs by Country
    5.1 North America Sexual Dysfunction Drugs Historic Market Size by Country
        5.1.1 North America Sexual Dysfunction Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
        5.1.2 North America Sexual Dysfunction Drugs Sales in Volume by Country (2018-2023)
        5.1.3 North America Sexual Dysfunction Drugs Sales in Value by Country (2018-2023)
    5.2 North America Sexual Dysfunction Drugs Forecasted Market Size by Country
        5.2.1 North America Sexual Dysfunction Drugs Sales in Volume by Country (2024-2029)
        5.2.2 North America Sexual Dysfunction Drugs Sales in Value by Country (2024-2029)

 6 Europe Sexual Dysfunction Drugs by Country
    6.1 Europe Sexual Dysfunction Drugs Historic Market Size by Country
        6.1.1 Europe Sexual Dysfunction Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
        6.1.2 Europe Sexual Dysfunction Drugs Sales in Volume by Country (2018-2023)
        6.1.3 Europe Sexual Dysfunction Drugs Sales in Value by Country (2018-2023)
    6.2 Europe Sexual Dysfunction Drugs Forecasted Market Size by Country
        6.2.1 Europe Sexual Dysfunction Drugs Sales in Volume by Country (2024-2029)
        6.2.2 Europe Sexual Dysfunction Drugs Sales in Value by Country (2024-2029)

 7 Asia-Pacific Sexual Dysfunction Drugs by Region
    7.1 Asia-Pacific Sexual Dysfunction Drugs Historic Market Size by Region
        7.1.1 Asia-Pacific Sexual Dysfunction Drugs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
        7.1.2 Asia-Pacific Sexual Dysfunction Drugs Sales in Volume by Region (2018-2023)
        7.1.3 Asia-Pacific Sexual Dysfunction Drugs Sales in Value by Region (2018-2023)
    7.2 Asia-Pacific Sexual Dysfunction Drugs Forecasted Market Size by Region
        7.2.1 Asia-Pacific Sexual Dysfunction Drugs Sales in Volume by Region (2024-2029)
        7.2.2 Asia-Pacific Sexual Dysfunction Drugs Sales in Value by Region (2024-2029)

 8 Latin America Sexual Dysfunction Drugs by Country
    8.1 Latin America Sexual Dysfunction Drugs Historic Market Size by Country
        8.1.1 Latin America Sexual Dysfunction Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
        8.1.2 Latin America Sexual Dysfunction Drugs Sales in Volume by Country (2018-2023)
        8.1.3 Latin America Sexual Dysfunction Drugs Sales in Value by Country (2018-2023)
    8.2 Latin America Sexual Dysfunction Drugs Forecasted Market Size by Country
        8.2.1 Latin America Sexual Dysfunction Drugs Sales in Volume by Country (2024-2029)
        8.2.2 Latin America Sexual Dysfunction Drugs Sales in Value by Country (2024-2029)

 9 Middle East and Africa Sexual Dysfunction Drugs by Country
    9.1 Middle East and Africa Sexual Dysfunction Drugs Historic Market Size by Country
        9.1.1 Middle East and Africa Sexual Dysfunction Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
        9.1.2 Middle East and Africa Sexual Dysfunction Drugs Sales in Volume by Country (2018-2023)
        9.1.3 Middle East and Africa Sexual Dysfunction Drugs Sales in Value by Country (2018-2023)
    9.2 Middle East and Africa Sexual Dysfunction Drugs Forecasted Market Size by Country
        9.2.1 Middle East and Africa Sexual Dysfunction Drugs Sales in Volume by Country (2024-2029)
        9.2.2 Middle East and Africa Sexual Dysfunction Drugs Sales in Value by Country (2024-2029)

 10 Company Profiles
    10.1 Pfizer
        10.1.1 Pfizer Company Information
        10.1.2 Pfizer Introduction and Business Overview
        10.1.3 Pfizer Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2018-2023)
        10.1.4 Pfizer Sexual Dysfunction Drugs Products Offered
        10.1.5 Pfizer Recent Development
    10.2 GlaxoSmithKline
        10.2.1 GlaxoSmithKline Company Information
        10.2.2 GlaxoSmithKline Introduction and Business Overview
        10.2.3 GlaxoSmithKline Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2018-2023)
        10.2.4 GlaxoSmithKline Sexual Dysfunction Drugs Products Offered
        10.2.5 GlaxoSmithKline Recent Development
    10.3 Merck
        10.3.1 Merck Company Information
        10.3.2 Merck Introduction and Business Overview
        10.3.3 Merck Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2018-2023)
        10.3.4 Merck Sexual Dysfunction Drugs Products Offered
        10.3.5 Merck Recent Development
    10.4 Eli Lilly
        10.4.1 Eli Lilly Company Information
        10.4.2 Eli Lilly Introduction and Business Overview
        10.4.3 Eli Lilly Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2018-2023)
        10.4.4 Eli Lilly Sexual Dysfunction Drugs Products Offered
        10.4.5 Eli Lilly Recent Development
    10.5 AbbVie
        10.5.1 AbbVie Company Information
        10.5.2 AbbVie Introduction and Business Overview
        10.5.3 AbbVie Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2018-2023)
        10.5.4 AbbVie Sexual Dysfunction Drugs Products Offered
        10.5.5 AbbVie Recent Development
    10.6 Bayer
        10.6.1 Bayer Company Information
        10.6.2 Bayer Introduction and Business Overview
        10.6.3 Bayer Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2018-2023)
        10.6.4 Bayer Sexual Dysfunction Drugs Products Offered
        10.6.5 Bayer Recent Development
    10.7 Teva Pharmaceutical Industries
        10.7.1 Teva Pharmaceutical Industries Company Information
        10.7.2 Teva Pharmaceutical Industries Introduction and Business Overview
        10.7.3 Teva Pharmaceutical Industries Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2018-2023)
        10.7.4 Teva Pharmaceutical Industries Sexual Dysfunction Drugs Products Offered
        10.7.5 Teva Pharmaceutical Industries Recent Development
    10.8 Takeda
        10.8.1 Takeda Company Information
        10.8.2 Takeda Introduction and Business Overview
        10.8.3 Takeda Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2018-2023)
        10.8.4 Takeda Sexual Dysfunction Drugs Products Offered
        10.8.5 Takeda Recent Development
    10.9 Apricus Biosciences
        10.9.1 Apricus Biosciences Company Information
        10.9.2 Apricus Biosciences Introduction and Business Overview
        10.9.3 Apricus Biosciences Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2018-2023)
        10.9.4 Apricus Biosciences Sexual Dysfunction Drugs Products Offered
        10.9.5 Apricus Biosciences Recent Development
    10.10 Emotional Brain
        10.10.1 Emotional Brain Company Information
        10.10.2 Emotional Brain Introduction and Business Overview
        10.10.3 Emotional Brain Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2018-2023)
        10.10.4 Emotional Brain Sexual Dysfunction Drugs Products Offered
        10.10.5 Emotional Brain Recent Development
    10.11 Ivix LLX
        10.11.1 Ivix LLX Company Information
        10.11.2 Ivix LLX Introduction and Business Overview
        10.11.3 Ivix LLX Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2018-2023)
        10.11.4 Ivix LLX Sexual Dysfunction Drugs Products Offered
        10.11.5 Ivix LLX Recent Development
    10.12 Leadiant Biosciences
        10.12.1 Leadiant Biosciences Company Information
        10.12.2 Leadiant Biosciences Introduction and Business Overview
        10.12.3 Leadiant Biosciences Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2018-2023)
        10.12.4 Leadiant Biosciences Sexual Dysfunction Drugs Products Offered
        10.12.5 Leadiant Biosciences Recent Development
    10.13 NexMed
        10.13.1 NexMed Company Information
        10.13.2 NexMed Introduction and Business Overview
        10.13.3 NexMed Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2018-2023)
        10.13.4 NexMed Sexual Dysfunction Drugs Products Offered
        10.13.5 NexMed Recent Development
    10.14 S1 Biopharma
        10.14.1 S1 Biopharma Company Information
        10.14.2 S1 Biopharma Introduction and Business Overview
        10.14.3 S1 Biopharma Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2018-2023)
        10.14.4 S1 Biopharma Sexual Dysfunction Drugs Products Offered
        10.14.5 S1 Biopharma Recent Development
    10.15 Vietstar Biomedical Research
        10.15.1 Vietstar Biomedical Research Company Information
        10.15.2 Vietstar Biomedical Research Introduction and Business Overview
        10.15.3 Vietstar Biomedical Research Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2018-2023)
        10.15.4 Vietstar Biomedical Research Sexual Dysfunction Drugs Products Offered
        10.15.5 Vietstar Biomedical Research Recent Development

 11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
    11.1 Sexual Dysfunction Drugs Key Raw Materials
        11.1.1 Key Raw Materials
        11.1.2 Key Raw Materials Price
        11.1.3 Raw Materials Key Suppliers
    11.2 Manufacturing Cost Structure
        11.2.1 Raw Materials
        11.2.2 Labor Cost
        11.2.3 Manufacturing Expenses
    11.3 Sexual Dysfunction Drugs Industrial Chain Analysis
    11.4 Sexual Dysfunction Drugs Market Dynamics
        11.4.1 Sexual Dysfunction Drugs Industry Trends
        11.4.2 Sexual Dysfunction Drugs Market Drivers
        11.4.3 Sexual Dysfunction Drugs Market Challenges
        11.4.4 Sexual Dysfunction Drugs Market Restraints

 12 Market Strategy Analysis, Distributors
    12.1 Sales Channel
    12.2 Sexual Dysfunction Drugs Distributors
    12.3 Sexual Dysfunction Drugs Downstream Customers

 13 Research Findings and Conclusion

 14 Appendix
    14.1 Research Methodology
        14.1.1 Methodology/Research Approach
        14.1.2 Data Source
    14.2 Author Details
    14.3 Disclaimer

List of Tables
    Table 1. Major Company of Oral Therapy
    Table 2. Major Company of Intracavernosal Therapy
    Table 3. Major Company of Hormonal Therapy
    Table 4. Major Company of Transurethral Therapy
    Table 5. Global Sexual Dysfunction Drugs Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
    Table 6. Global Sexual Dysfunction Drugs Sales by Type (2018-2023) & (K Pcs)
    Table 7. Global Sexual Dysfunction Drugs Sales Market Share in Volume by Type (2018-2023)
    Table 8. Global Sexual Dysfunction Drugs Sales by Type (2018-2023) & (US& Million)
    Table 9. Global Sexual Dysfunction Drugs Market Share in Value by Type (2018-2023)
    Table 10. Global Sexual Dysfunction Drugs Price by Type (2018-2023) & (USD/Pcs)
    Table 11. Global Sexual Dysfunction Drugs Sales by Type (2024-2029) & (K Pcs)
    Table 12. Global Sexual Dysfunction Drugs Sales Market Share in Volume by Type (2024-2029)
    Table 13. Global Sexual Dysfunction Drugs Sales by Type (2024-2029) & (US$ Million)
    Table 14. Global Sexual Dysfunction Drugs Sales Market Share in Value by Type (2024-2029)
    Table 15. Global Sexual Dysfunction Drugs Price by Type (2024-2029) & (USD/Pcs)
    Table 16. North America Sexual Dysfunction Drugs Sales by Type (2018-2023) & (K Pcs)
    Table 17. North America Sexual Dysfunction Drugs Sales by Type (2018-2023) & (US$ Million)
    Table 18. Europe Sexual Dysfunction Drugs Sales (K Pcs) by Type (2018-2023)
    Table 19. Europe Sexual Dysfunction Drugs Sales by Type (2018-2023) & (US$ Million)
    Table 20. Asia-Pacific Sexual Dysfunction Drugs Sales (K Pcs) by Type (2018-2023)
    Table 21. Asia-Pacific Sexual Dysfunction Drugs Sales by Type (2018-2023) & (US$ Million)
    Table 22. Latin America Sexual Dysfunction Drugs Sales (K Pcs) by Type (2018-2023)
    Table 23. Latin America Sexual Dysfunction Drugs Sales by Type (2018-2023) & (US$ Million)
    Table 24. Middle East and Africa Sexual Dysfunction Drugs Sales (K Pcs) by Type (2018-2023)
    Table 25. Middle East and Africa Sexual Dysfunction Drugs Sales by Type (2018-2023) & (US$ Million)
    Table 26. Global Sexual Dysfunction Drugs Sales by Company (2018-2023) & (K Pcs)
    Table 27. Global Sexual Dysfunction Drugs Sales Share by Company (2018-2023)
    Table 28. Global Sexual Dysfunction Drugs Revenue by Company (2018-2023) & (US$ Million)
    Table 29. Global Sexual Dysfunction Drugs Revenue Share by Company (2018-2023)
    Table 30. Global Market Sexual Dysfunction Drugs Price by Company (2018-2023) & (USD/Pcs)
    Table 31. Global Sexual Dysfunction Drugs Top Manufacturers Manufacturing Base Distribution and Sales Area
    Table 32. Global Sexual Dysfunction Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Sexual Dysfunction Drugs as of 2022)
    Table 34. Date of Key Manufacturers Enter into Sexual Dysfunction Drugs Market
    Table 35. Key Manufacturers Sexual Dysfunction Drugs Product Type
    Table 36. Mergers & Acquisitions, Expansion Plans
    Table 37. Global Sexual Dysfunction Drugs Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 38. Global Sexual Dysfunction Drugs Sales by Region (2018-2023) & (K Pcs)
    Table 39. Global Sexual Dysfunction Drugs Sales Market Share in Volume by Region (2018-2023)
    Table 40. Global Sexual Dysfunction Drugs Sales by Region (2018-2023) & (US$ Million)
    Table 41. Global Sexual Dysfunction Drugs Sales Market Share in Value by Region (2018-2023)
    Table 42. Global Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 43. Global Sexual Dysfunction Drugs Sales by Region (2024-2029) & (K Pcs)
    Table 44. Global Sexual Dysfunction Drugs Sales Market Share in Volume by Region (2024-2029)
    Table 45. Global Sexual Dysfunction Drugs Sales by Region (2024-2029) & (US$ Million)
    Table 46. Global Sexual Dysfunction Drugs Sales Market Share in Value by Region (2024-2029)
    Table 47. Global Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2029)
    Table 48. Global Sexual Dysfunction Drugs Sales by User: 2018 VS 2022 VS 2029 (US$ Million)
    Table 49. Global Sexual Dysfunction Drugs Sales by User (2018-2023) & (K Pcs)
    Table 50. Global Sexual Dysfunction Drugs Sales Market Share in Volume by User (2018-2023)
    Table 51. Global Sexual Dysfunction Drugs Sales by User (2018-2023) & (US$ Million)
    Table 52. Global Sexual Dysfunction Drugs Sales Market Share in Value by User (2018-2023)
    Table 53. Global Sexual Dysfunction Drugs Price by User (2018-2023) & (USD/Pcs)
    Table 54. Global Sexual Dysfunction Drugs Sales by User (2024-2029) & (K Pcs)
    Table 55. Global Sexual Dysfunction Drugs Sales Market Share in Volume by User (2024-2029)
    Table 56. Global Sexual Dysfunction Drugs Sales by User (2024-2029) & (US$ Million)
    Table 57. Global Sexual Dysfunction Drugs Sales Market Share in Value by User (2024-2029)
    Table 58. Global Sexual Dysfunction Drugs Price by User (2024-2029) & (USD/Pcs)
    Table 59. North America Sexual Dysfunction Drugs Sales by User (2018-2023) (K Pcs) 
    Table 60. North America Sexual Dysfunction Drugs Sales by User (2018-2023) & (US$ Million)
    Table 61. Europe Sexual Dysfunction Drugs Sales by User (2018-2023) (K Pcs) 
    Table 62. Europe Sexual Dysfunction Drugs Sales by User (2018-2023) & (US$ Million)
    Table 63. Asia-Pacific Sexual Dysfunction Drugs Sales by User (2018-2023) (K Pcs) 
    Table 64. Asia-Pacific Sexual Dysfunction Drugs Sales by User (2018-2023) & (US$ Million)
    Table 65. Latin America Sexual Dysfunction Drugs Sales by User (2018-2023) (K Pcs) 
    Table 66. Latin America Sexual Dysfunction Drugs Sales by User (2018-2023) & (US$ Million)
    Table 67. Middle East and Africa Sexual Dysfunction Drugs Sales by User (2018-2023) (K Pcs) 
    Table 68. Middle East and Africa Sexual Dysfunction Drugs Sales by User (2018-2023) & (US$ Million)
    Table 69. North America Sexual Dysfunction Drugs Sales by Country (2018-2023) & (K Pcs)
    Table 70. North America Sexual Dysfunction Drugs Sales Market Share in Volume by Country (2018-2023)
    Table 71. North America Sexual Dysfunction Drugs Sales by Country (2018-2023) & (US$ Million)
    Table 72. North America Sexual Dysfunction Drugs Sales Market Share in Value by Country (2018-2023)
    Table 73. North America Sexual Dysfunction Drugs Sales by Country (2024-2029) & (K Pcs)
    Table 74. North America Sexual Dysfunction Drugs Sales Market Share in Volume by Country (2024-2029)
    Table 75. North America Sexual Dysfunction Drugs Sales by Country (2024-2029) & (US$ Million)
    Table 76. North America Sexual Dysfunction Drugs Sales Market Share in Value by Country (2024-2029)
    Table 77. Europe Sexual Dysfunction Drugs Sales by Country (2018-2023) & (K Pcs)
    Table 78. Europe Sexual Dysfunction Drugs Sales Market Share in Volume by Country (2018-2023)
    Table 79. Europe Sexual Dysfunction Drugs Sales by Country (2018-2023) & (US$ Million)
    Table 80. Europe Sexual Dysfunction Drugs Sales Market Share in Value by Country (2018-2023)
    Table 81. Europe Sexual Dysfunction Drugs Sales by Country (2024-2029) & (K Pcs)
    Table 82. Europe Sexual Dysfunction Drugs Sales Market Share in Volume by Country (2024-2029)
    Table 83. Europe Sexual Dysfunction Drugs Sales by Country (2024-2029) & (US$ Million)
    Table 84. Europe Sexual Dysfunction Drugs Sales Market Share in Value by Country (2024-2029)
    Table 85. Asia-Pacific Sexual Dysfunction Drugs Sales by Region (2018-2023) & (K Pcs)
    Table 86. Asia-Pacific Sexual Dysfunction Drugs Sales Market Share in Volume by Region (2018-2023)
    Table 87. Asia-Pacific Sexual Dysfunction Drugs Sales by Region (2018-2023) & (US$ Million)
    Table 88. Asia-Pacific Sexual Dysfunction Drugs Sales Market Share in Value by Region (2018-2023)
    Table 89. Asia-Pacific Sexual Dysfunction Drugs Sales by Region (2024-2029) & (K Pcs)
    Table 90. Asia-Pacific Sexual Dysfunction Drugs Sales Market Share in Volume by Region (2024-2029)
    Table 91. Asia-Pacific Sexual Dysfunction Drugs Sales by Region (2024-2029) & (US$ Million)
    Table 92. Asia-Pacific Sexual Dysfunction Drugs Sales Market Share in Value by Region (2024-2029)
    Table 93. Latin America Sexual Dysfunction Drugs Sales by Country (2018-2023) & (K Pcs)
    Table 94. Latin America Sexual Dysfunction Drugs Sales Market Share in Volume by Country (2018-2023)
    Table 95. Latin America Sexual Dysfunction Drugs Sales by Country (2018-2023) & (US$ Million)
    Table 96. Latin America Sexual Dysfunction Drugs Sales Market Share in Value by Country (2018-2023)
    Table 97. Latin America Sexual Dysfunction Drugs Sales by Country (2024-2029) & (K Pcs)
    Table 98. Latin America Sexual Dysfunction Drugs Sales Market Share in Volume by Country (2024-2029)
    Table 99. Latin America Sexual Dysfunction Drugs Sales by Country (2024-2029) & (US$ Million)
    Table 100. Latin America Sexual Dysfunction Drugs Sales Market Share in Value by Country (2024-2029)
    Table 101. Middle East and Africa Sexual Dysfunction Drugs Sales by Country (2018-2023) & (K Pcs)
    Table 102. Middle East and Africa Sexual Dysfunction Drugs Sales Market Share in Volume by Country (2018-2023)
    Table 103. Middle East and Africa Sexual Dysfunction Drugs Sales by Country (2018-2023) & (US$ Million)
    Table 104. Middle East and Africa Sexual Dysfunction Drugs Sales Market Share in Value by Country (2018-2023)
    Table 105. Middle East and Africa Sexual Dysfunction Drugs Sales by Country (2024-2029) & (K Pcs)
    Table 106. Middle East and Africa Sexual Dysfunction Drugs Sales Market Share in Volume by Country (2024-2029)
    Table 107. Middle East and Africa Sexual Dysfunction Drugs Sales by Country (2024-2029) & (US$ Million)
    Table 108. Middle East and Africa Sexual Dysfunction Drugs Sales Market Share in Value by Country (2024-2029)
    Table 109. Pfizer Company Information
    Table 110. Pfizer Introduction and Business Overview
    Table 111. Pfizer Sexual Dysfunction Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 112. Pfizer Sexual Dysfunction Drugs Product
    Table 113. Pfizer Recent Development
    Table 114. GlaxoSmithKline Company Information
    Table 115. GlaxoSmithKline Introduction and Business Overview
    Table 116. GlaxoSmithKline Sexual Dysfunction Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 117. GlaxoSmithKline Sexual Dysfunction Drugs Product
    Table 118. GlaxoSmithKline Recent Development
    Table 119. Merck Company Information
    Table 120. Merck Introduction and Business Overview
    Table 121. Merck Sexual Dysfunction Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 122. Merck Sexual Dysfunction Drugs Product
    Table 123. Merck Recent Development
    Table 124. Eli Lilly Company Information
    Table 125. Eli Lilly Introduction and Business Overview
    Table 126. Eli Lilly Sexual Dysfunction Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 127. Eli Lilly Sexual Dysfunction Drugs Product
    Table 128. Eli Lilly Recent Development
    Table 129. AbbVie Company Information
    Table 130. AbbVie Introduction and Business Overview
    Table 131. AbbVie Sexual Dysfunction Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 132. AbbVie Sexual Dysfunction Drugs Product
    Table 133. AbbVie Recent Development
    Table 134. Bayer Company Information
    Table 135. Bayer Introduction and Business Overview
    Table 136. Bayer Sexual Dysfunction Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 137. Bayer Sexual Dysfunction Drugs Product
    Table 138. Bayer Recent Development
    Table 139. Teva Pharmaceutical Industries Company Information
    Table 140. Teva Pharmaceutical Industries Introduction and Business Overview
    Table 141. Teva Pharmaceutical Industries Sexual Dysfunction Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 142. Teva Pharmaceutical Industries Sexual Dysfunction Drugs Product
    Table 143. Teva Pharmaceutical Industries Recent Development
    Table 144. Takeda Company Information
    Table 145. Takeda Introduction and Business Overview
    Table 146. Takeda Sexual Dysfunction Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 147. Takeda Sexual Dysfunction Drugs Product
    Table 148. Takeda Recent Development
    Table 149. Apricus Biosciences Company Information
    Table 150. Apricus Biosciences Introduction and Business Overview
    Table 151. Apricus Biosciences Sexual Dysfunction Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 152. Apricus Biosciences Sexual Dysfunction Drugs Product
    Table 153. Apricus Biosciences Recent Development
    Table 154. Emotional Brain Company Information
    Table 155. Emotional Brain Introduction and Business Overview
    Table 156. Emotional Brain Sexual Dysfunction Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 157. Emotional Brain Sexual Dysfunction Drugs Product
    Table 158. Emotional Brain Recent Development
    Table 159. Ivix LLX Company Information
    Table 160. Ivix LLX Introduction and Business Overview
    Table 161. Ivix LLX Sexual Dysfunction Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 162. Ivix LLX Sexual Dysfunction Drugs Product
    Table 163. Ivix LLX Recent Development
    Table 164. Leadiant Biosciences Company Information
    Table 165. Leadiant Biosciences Introduction and Business Overview
    Table 166. Leadiant Biosciences Sexual Dysfunction Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 167. Leadiant Biosciences Sexual Dysfunction Drugs Product
    Table 168. Leadiant Biosciences Recent Development
    Table 169. NexMed Company Information
    Table 170. NexMed Introduction and Business Overview
    Table 171. NexMed Sexual Dysfunction Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 172. NexMed Sexual Dysfunction Drugs Product
    Table 173. NexMed Recent Development
    Table 174. S1 Biopharma Company Information
    Table 175. S1 Biopharma Introduction and Business Overview
    Table 176. S1 Biopharma Sexual Dysfunction Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 177. S1 Biopharma Sexual Dysfunction Drugs Product
    Table 178. S1 Biopharma Recent Development
    Table 179. Vietstar Biomedical Research Company Information
    Table 180. Vietstar Biomedical Research Introduction and Business Overview
    Table 181. Vietstar Biomedical Research Sexual Dysfunction Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 182. Vietstar Biomedical Research Sexual Dysfunction Drugs Product
    Table 183. Vietstar Biomedical Research Recent Development
    Table 184. Key Raw Materials Lists
    Table 185. Raw Materials Key Suppliers Lists
    Table 186. Sexual Dysfunction Drugs Market Trends
    Table 187. Sexual Dysfunction Drugs Market Drivers
    Table 188. Sexual Dysfunction Drugs Market Challenges
    Table 189. Sexual Dysfunction Drugs Market Restraints
    Table 190. Sexual Dysfunction Drugs Distributors List
    Table 191. Sexual Dysfunction Drugs Downstream Customers
    Table 192. Research Programs/Design for This Report
    Table 193. Key Data Information from Secondary Sources
    Table 194. Key Data Information from Primary Sources
List of Figures
    Figure 1. Sexual Dysfunction Drugs Product Picture
    Figure 2. Global Sexual Dysfunction Drugs Market Size, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 3. Global Sexual Dysfunction Drugs Market Size Status and Outlook (2018-2029) & (US$ Million)
    Figure 4. Global Sexual Dysfunction Drugs Sales Status and Outlook (2018-2029) & (K Pcs)
    Figure 5. Product Picture of Oral Therapy
    Figure 6. Global Oral Therapy Sales YoY Growth (2018-2029) & (K Pcs)
    Figure 7. Product Picture of Intracavernosal Therapy
    Figure 8. Global Intracavernosal Therapy Sales YoY Growth (2018-2029) & (K Pcs)
    Figure 9. Product Picture of Hormonal Therapy
    Figure 10. Global Hormonal Therapy Sales YoY Growth (2018-2029) & (K Pcs)
    Figure 11. Product Picture of Transurethral Therapy
    Figure 12. Global Transurethral Therapy Sales YoY Growth (2018-2029) & (K Pcs)
    Figure 13. Global Sexual Dysfunction Drugs Sales by Type (2018-2029) & (US$ Million)
    Figure 14. Global Sexual Dysfunction Drugs Sales Market Share by Type in 2022 & 2029
    Figure 15. North America Sexual Dysfunction Drugs Sales Market Share in Volume by Type in 2022
    Figure 16. North America Sexual Dysfunction Drugs Sales Market Share in Value by Type in 2022
    Figure 17. Europe Sexual Dysfunction Drugs Sales Market Share in Volume by Type in 2022
    Figure 18. Europe Sexual Dysfunction Drugs Sales Market Share in Value by Type in 2022
    Figure 19. Asia-Pacific Sexual Dysfunction Drugs Sales Market Share in Volume by Type in 2022
    Figure 20. Asia-Pacific Sexual Dysfunction Drugs Sales Market Share in Value by Type in 2022
    Figure 21. Latin America Sexual Dysfunction Drugs Sales Market Share in Volume by Type in 2022
    Figure 22. Latin America Sexual Dysfunction Drugs Sales Market Share in Value by Type in 2022
    Figure 23. Middle East and Africa Sexual Dysfunction Drugs Sales Market Share in Volume by Type in 2022
    Figure 24. Middle East and Africa Sexual Dysfunction Drugs Sales Market Share in Value by Type in 2022
    Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Sexual Dysfunction Drugs Sales in 2022
    Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Sexual Dysfunction Drugs Revenue in 2022
    Figure 27. Sexual Dysfunction Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
    Figure 28. Product Picture of Male
    Figure 29. Global Male Sales YoY Growth (2018-2029) & (K Pcs)
    Figure 30. Product Picture of Female
    Figure 31. Global Female Sales YoY Growth (2018-2029) & (K Pcs)
    Figure 32. Global Sexual Dysfunction Drugs Sales by User (2018-2029) & (US$ Million)
    Figure 33. Global Sexual Dysfunction Drugs Sales Market Share by User in 2022 & 2029
    Figure 34. North America Sexual Dysfunction Drugs Sales Market Share in Volume by User in 2022
    Figure 35. North America Sexual Dysfunction Drugs Sales Market Share in Value by User in 2022
    Figure 36. Europe Sexual Dysfunction Drugs Sales Market Share in Volume by User in 2022
    Figure 37. Europe Sexual Dysfunction Drugs Sales Market Share in Value by User in 2022
    Figure 38. Asia-Pacific Sexual Dysfunction Drugs Sales Market Share in Volume by User in 2022
    Figure 39. Asia-Pacific Sexual Dysfunction Drugs Sales Market Share in Value by User in 2022
    Figure 40. Latin America Sexual Dysfunction Drugs Sales Market Share in Volume by User in 2022
    Figure 41. Latin America Sexual Dysfunction Drugs Sales Market Share in Value by User in 2022
    Figure 42. Middle East and Africa Sexual Dysfunction Drugs Sales Market Share in Value by User in 2022
    Figure 43. Key Raw Materials Price
    Figure 44. Sexual Dysfunction Drugs Manufacturing Cost Structure
    Figure 45. Sexual Dysfunction Drugs Industrial Chain Analysis
    Figure 46. Channels of Distribution
    Figure 47. Distributors Profiles
    Figure 48. Bottom-up and Top-down Approaches for This Report
    Figure 49. Data Triangulation
    Figure 50. Key Executives Interviewed

Sexual dysfunctions include sexual disorders of men and women that can interfere with their sexual performance, leading to unsatisfied sexual intercourse. The major drugs used in this market are PDE5 inhibitors, whereas other drugs such as hormone-related and transurethral also have a presence in the market.

Sexual Dysfunction Drugs report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Sexual Dysfunction Drugs market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Demand from Male and Female are the major drivers for the industry.

The sexual dysfunction oral drugs segment accounted for the majority market share during 2017 and will continue to grow during the forecast period. The increasing cases of sexual dysfunctions are driving the need for oral therapies such as 5HT1A receptor agonist. The demand for sexual dysfunction oral drugs such as ED drugs will further increase due to the rising awareness among healthcare professionals.

Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Sexual Dysfunction Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Manufacturers, Type, User and Regions Listed in the Report:
By Company
    Pfizer
    GlaxoSmithKline
    Merck
    Eli Lilly
    AbbVie
    Bayer
    Teva Pharmaceutical Industries
    Takeda
    Apricus Biosciences
    Emotional Brain
    Ivix LLX
    Leadiant Biosciences
    NexMed
    S1 Biopharma
    Vietstar Biomedical Research

Segment by Type
    Oral Therapy
    Intracavernosal Therapy
    Hormonal Therapy
    Transurethral Therapy

Segment by User
    Male
    Female

Segment by Region
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        China Taiwan
        Indonesia
        Thailand
        Malaysia
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

Each chapter of the report provides detailed information for readers to understand the Sexual Dysfunction Drugs market further:
Chapter 1: Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 2: Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Sexual Dysfunction Drugs, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Sexual Dysfunction Drugs industry.
Chapter 3: Historical (2018-2022) and forecast (2023-2029) volume and revenue analysis of Sexual Dysfunction Drugs in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4: Product User, Volume and Revenue analysis of Each User in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 5 to 9: Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10: Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Sexual Dysfunction Drugs introduction, etc. Sexual Dysfunction Drugs Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11: Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12: Market Channel, Distributors and Customers are listed.
Chapter 13: QYResearch’s Conclusions of Sexual Dysfunction Drugs market based on comprehensive survey.
Chapter 14: Methodology and Data Sources adopted by QYResearch.